Stock

Parabilis Medicines, Inc. PBLS

$31.03-5.70%

All stocks Create account to unlock

Overview

PBLS market data

Price History

PBLS price chart

Valuation & Profitability

no valuation data

No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for PBLS. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Company news

4 captured

Leerink Partners Initiates Coverage On Parabilis Medicines with Outperform Rating, Announces Price Target of $40 · Jul 6, 2026, 11:30 AM

This Parabilis Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday · Jul 6, 2026, 11:15 AM

Parabilis Medicines Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares · Jun 11, 2026, 9:15 PM

8-K filing — Parabilis Medicines, Inc. (PBLS) · Jun 11, 2026, 8:12 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock